Can Basilea’s Antibiotic Succeed Where Others Have Failed?
Company Looks To Partner Ceftobiprole Ahead Of US Approval
The Swiss biotech says the ERADICATE trial shows areas of differentiation for the antibiotic, like utility in pneumonia and across gram-negative and gram-positive bacteria.
